Europe Osteoarthritis Epidemiology and Patient Flow Analysis - 2017

Europe Osteoarthritis Epidemiology and Patient Flow Analysis - 2017

  • January 2017 •
  • Report ID: 4835146 •
  • Format: PDF
Fore Pharma announced the results of its Osteoarthritis patients study in a new report ‘Europe Osteoarthritis Epidemiology and Patient Flow Analysis - 2017’.

The report provides insights into Osteoarthritis epidemiology, Osteoarthritis diagnosed patients, and Osteoarthritis treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Osteoarthritis derived from epidemiological analysis, percentage of patients diagnosed with Osteoarthritis, and percentage of patients treated with a therapy.

The study helps executives estimate Osteoarthritis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Osteoarthritis prevalence, Osteoarthritis diagnosis rate, and Osteoarthritis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Osteoarthritis Patient Flow
- Osteoarthritis Prevalence
- Osteoarthritis Diagnosed Patients
- Osteoarthritis Treated Patients